Factors for achieving target serum uric acid levels after initiating urate-lowering therapy in patients with gout: results from the ULTRA registry
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Factors for achieving target serum uric acid levels after initiating urate-lowering therapy in patients with gout: results from the ULTRA registry ; volume:13 ; number:1 ; day:22 ; month:11 ; year:2023 ; pages:1-7 ; date:12.2023
Scientific reports ; 13, Heft 1 (22.11.2023), 1-7, 12.2023
- Urheber
-
Do, Hyunsue
Choi, Hyo Jin
Choi, Byoongyong
Son, Chang-Nam
Kim, Sang-Hyon
Choi, Se Rim
Kim, Ji Hyoun
Kim, Min Jung
Shin, Kichul
Kim, Hyun-Ok
Song, Ran
Lee, Sung Won
Ahn, Joong Kyong
Lee, Seung-Geun
Lee, Chang Hoon
Son, Kyeong Min
Moon, Ki Won
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-47790-6
- URN
-
urn:nbn:de:101:1-2024021211240089824473
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Do, Hyunsue
- Choi, Hyo Jin
- Choi, Byoongyong
- Son, Chang-Nam
- Kim, Sang-Hyon
- Choi, Se Rim
- Kim, Ji Hyoun
- Kim, Min Jung
- Shin, Kichul
- Kim, Hyun-Ok
- Song, Ran
- Lee, Sung Won
- Ahn, Joong Kyong
- Lee, Seung-Geun
- Lee, Chang Hoon
- Son, Kyeong Min
- Moon, Ki Won
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Benefits of uric acid-lowering medication after bariatric surgery in patients with gout
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?
The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Benefits of uric acid-lowering medication after bariatric surgery in patients with gout
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?
The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
Benefits of uric acid-lowering medication after bariatric surgery in patients with gout
Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
Urate lowering therapy in patients starting hemodialysis limit gout flares occurrence: ten years retrospective study
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?